Panagiotis Stafylas

ORCID: 0000-0001-8550-5451
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmaceutical Economics and Policy
  • Blood Pressure and Hypertension Studies
  • Heart Failure Treatment and Management
  • Chronic Disease Management Strategies
  • Chronic Kidney Disease and Diabetes
  • Medication Adherence and Compliance
  • Cardiac pacing and defibrillation studies
  • Healthcare Systems and Practices
  • Acute Ischemic Stroke Management
  • Cardiac Health and Mental Health
  • Healthcare Policy and Management
  • Economic and Financial Impacts of Cancer
  • Diabetes Treatment and Management
  • Biosimilars and Bioanalytical Methods
  • Peroxisome Proliferator-Activated Receptors
  • Liver Disease Diagnosis and Treatment
  • Dialysis and Renal Disease Management
  • Healthcare Systems and Public Health
  • Pharmaceutical industry and healthcare
  • Geriatric Care and Nursing Homes
  • Global Health Care Issues
  • Hormonal Regulation and Hypertension
  • Lipoproteins and Cardiovascular Health
  • Diabetes, Cardiovascular Risks, and Lipoproteins

OPKO Health (Ireland)
2023

Aristotle University of Thessaloniki
2007-2023

Athens Medical Center
2023

Health Information Management
2014-2018

Information Management Services
2018

University of Macedonia
2016

Information & Image Management Systems (Spain)
2016

Hellenic Agency for Local Development and Local Government
2015

AHEPA University Hospital
2005-2012

Veria General Hospital
2008

Chronic kidney disease (CKD) is a global concern that presents significant challenges for management. Several factors drive CKD prevalence, including primary risk factors, such as type 2 diabetes and hypertension, an ageing population.

10.1016/j.eclinm.2024.102614 article EN cc-by EClinicalMedicine 2024-05-02

<sec> <title>BACKGROUND</title> Unhealthy lifestyle behaviors have been identified as a major cause of numerous health issues with steady global increase. Addressing this challenge requires comprehensive behavioral changes to promote sustainable healthier adoption. However, despite the prevalent need, cost effective and successful health-related behavior change virtual coaching, remain scarce. </sec> <title>OBJECTIVE</title> This paper presents holistic framework for designing, modeling...

10.2196/preprints.73807 preprint EN 2025-03-12

Cost‐containment measures in healthcare provision include the implementation of therapeutic and generic drug substitution strategies patients whose condition is already well controlled with pharmacotherapy. Treatment for hypertension frequently targeted such measures. However, acquisition costs are only part cost‐effectiveness equation, a variety other factors need to be taken into account when assessing impact switching antihypertensives. From clinical perspective, considerations...

10.1111/j.1365-2125.2010.03681.x article EN British Journal of Clinical Pharmacology 2010-04-12

Background:Type 2 diabetes mellitus (DM) affects 382 million people worldwide.Introduction:This study aimed at assessing whether telemonitoring (TM) of DM patients improves health-related quality life (HRQoL).Materials and Methods:As part the RENEWING HEALTH project, 299 with HbA1c >7.0% were enrolled in a randomized controlled trial, 208 TM group 91 usual-care group. electronically transmitted glucose measurements to physicians during 12-month follow-up. The SF-36v2 questionnaire was used...

10.1089/tmj.2015.0224 article EN Telemedicine Journal and e-Health 2016-07-05

Given the current financial climate there is an ever-increasing need to substitute drug treatments optimize expenditure. A closer examination of beliefs surrounding when substitution appropriate led a group European healthcare experts argue that in some cases these may be unfounded and guidelines are needed for clinical practice. The manage minimize costs increasingly important systems across world. Generic already used widely throughout Europe payers looking towards therapeutic make...

10.1111/j.1365-2125.2011.03987.x article EN British Journal of Clinical Pharmacology 2011-04-12

To evaluate the impact in terms of use health services, clinical outcomes, functional status, and patient's satisfaction an integrated care program, CareWell for complex patients with multimorbidity, supported by information communication technology platforms six European regions.Primary data were used follow-up period ranged between 8 12 months.A quasi-experimental study, targeting chronic aged 65 or older, 2 more conditions - one them necessarily being diabetes, congestive heart failure...

10.5334/ijic.4711 article EN cc-by International Journal of Integrated Care 2020-05-22

Background . The aim of the current study was to investigate physicians’ perceptions and adherence European guidelines for management hypertension. Methods This is a national, multicentre, prospective, observational study, conducted between November 2007 June 2008, in Cyprus. Consecutive hypertensive patients have been recruited by random sample physicians. recommendations every single patient recorded compared with ESH/ESC guidelines. Results Of total 654 patients, 477 (72.9%) were...

10.1155/2012/503821 article EN cc-by International Journal of Hypertension 2012-01-01

LifeChamps is an EU Horizon 2020 project that aims to create a digital platform enable monitoring of health-related quality life and frailty in patients with cancer over the age 65. Our primary objective assess feasibility, usability, acceptability, fidelity, adherence, safety parameters when implementing routine care. Secondary objectives involve evaluating preliminary signals efficacy cost-effectiveness indicators.

10.1016/j.soncn.2023.151437 article EN cc-by-nc-nd Seminars in Oncology Nursing 2023-05-05

Background: Although ranolazine has been available for years as a second-line treatment to reduce angina attacks in patients with stable pectoris, real-world data on the effectiveness, tolerability, and safety of are limited. Methods: A non-interventional, prospective study was conducted assess effectiveness ranolazine. Patients eligible enrolment had baseline assessment between one fourteen days after initiating first time follow-up visit three months later. The primary endpoints comprised...

10.3390/jcm13061672 article EN Journal of Clinical Medicine 2024-03-14

Information and communication technology may provide domiciliary care programs with continuity of care. However, evidence about the effectiveness cost-effectiveness information in context integrated models is relatively scarce.The objective our study was to on clinical BeyondSilos project for patients enrolled Badalona city pilot site Spain.A quasi-experimental used assess technology-enhanced integration health social care, including third sector (intervention), compared basic coordination...

10.2196/20938 article EN cc-by JMIR Medical Informatics 2020-09-06

The aim of this study was to compare the cost-utility first available single-pill triple combination antihypertensive therapy containing valsartan (V), amlodipine (A) and hydrochlorothiazide (H), with each same components dual combinations in patients moderate severe hypertension. A Markov model eight health states constructed. short-term effect treatment on blood pressure extrapolated through Hellenic SCORE Framingham risk equations, estimating long-term survival quality-adjusted life-years...

10.1186/s12962-015-0036-x article EN cc-by Cost Effectiveness and Resource Allocation 2015-06-09
Coming Soon ...